Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
ir.gemphire.com/...54241&p=irol-newsArticle&ID=2363275
www.fiercebiotech.com/biotech/...ne-fatty-liver-disease-trial
Werbung
| Strategie | Hebel | |||
| Steigender Citigroup Inc-Kurs | 4,89 | 9,27 | 13,34 | |
| Fallender Citigroup Inc-Kurs | 5,24 | 10,27 | 17,54 | |
|
Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
ir.gemphire.com/...54241&p=irol-newsArticle&ID=2363275
www.fiercebiotech.com/biotech/...ne-fatty-liver-disease-trial
kritischer Kommentar von AF
twitter.com/adamfeuerstein/status/1143860778090582017
Merger mit NeuroBo Pharmaceuticals
ir.gemphire.com/news-releases/...robo-pharmaceuticals-announce
Werbung
| Strategie | Hebel | |||
| Steigender Citigroup Inc-Kurs | 4,89 | 9,27 | 13,34 | |
| Fallender Citigroup Inc-Kurs | 5,24 | 10,27 | 17,54 | |
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 4 | GEMP 1,58$ (-52%) | Vassago | Vassago | 25.04.21 02:50 |